Tulane Home Tulane Home

IP Title

Multi-Antigen Diagnostic for Post-Treatment Lyme Disease Syndrome



Tulane University is actively seeking commercial entities to further develop and commercialize our multi-antigen diagnostic test for post-treatment Lyme disease.


Used to detect post-treatment Lyme disease syndrome. Improved serodiagnostic test for Lyme disease over the two-tier test and the C6 test. More sensitive and specific than currently available diagnostic tests. Five-antigen multiplex assay. First diagnostic test for post-treatment Lyme disease syndrome

Current Work

This technology has been tested extensively in the laboratory and in mice models.